Somany Ceramics Targets 1.5% EBITDA Margin Gain Despite Volatile Gas

Somany Ceramics Limited — Q4 FY26 & FY26 Earnings Call (15 May 2026)

1. Overall Tone of Management: Optimistic

• Management repeatedly frames the situation as a “positive” for organized/branded players and says they are “happy” with results.
• Forward-looking language is confident: “our guidance is to improve EBITDA margin… by at least 1.5% or more” and “we are very, very confident” the tile industry benefits if disruption doesn’t continue.
• They also highlight operational progress (e.g., Max plant breakeven) and expect further improvement.

2. Key Themes from Management Commentary

• Demand normalization with geopolitical disruption effects
• Domestic demand improved in Jan–Feb, while March was an “aberration” due to geopolitical issues and outages.
• Exports increased vs last year but were capped by “March outage, where nothing really went or sailed in March.”
• Gas price shock as the central variable
• Gas prices increased “very significantly” post-war; management emphasizes that input cost increases are being passed on “to an extent.”
• They provide detailed gas pricing ranges and note volatility in current pricing.
• Margin improvement driven by cost pass-through + capacity utilization
• EBITDA improved meaningfully: Q4 EBITDA margin 11.4% and FY EBITDA margin 9.3%.
• Capacity utilization largely flat at ~79% for FY, but Q4 improved to 82%.
• Operational turnaround signals
• Max plant near breakeven: Q4 breakeven vs prior-year loss (“loss was about INR 9 crores”).
• They also discuss investments to improve utilization/value-add (Max press; vintage plant balancing; bathware/vintage investments).
• Working capital discipline
• Receivables improved materially: 40 days vs 51 days (and standalone improvement mentioned).
• Working capital days marginally lower; they attribute improvement to vendor stock reduction and sale of older inventory.
• Strategic growth mix
• Tiles: GVT sales up ~3%, while ceramic/PVT down ~3%.
• Sanitaryware grew ~8% to INR 320 crores and management is targeting double-digit growth.

3. Q&A Analysis

Theme A: Working capital sustainability & demand timing

• Core questions
• How sustainable is the receivable/working capital improvement into FY27?
• How does demand split across Jan/Feb vs March (ex-crisis)?
• Management response
• Receivables: wants to keep them “around the same area” (may rise “a day or 2”).
• Working capital: improvement partly from outsourced vendor stock reduction and sale of >180-day inventory in March.
• Demand: Jan/Feb grew decent single digits; March was managed to avoid dumping and to clear vendor stock ahead of April price increases.
• Assessment
• Some hedging: sustainability is framed as controllable but “a question mark” due to delayed price absorption in April.

Theme B: Gas pricing mechanics, pass-through, and regional differentials

• Core questions
• Provide North/South/West gas pricing (Q4 and current).
• Morbi vs North gas differential and current pricing.
• How much of cost inflation is passed through to protect margins?
• Management response
• FY25/FY26 gas pricing described as largely flat historically, but current is “extremely volatile.”
• Morbi current (May): “INR74 plus 6% ballpark”; North about INR 3–4 cheaper.
• Pass-through: claims almost entire price increase taken; in retail “pass on 100%”, in projects ~85%.
• Assessment
• Strong specificity on pricing and pass-through percentages.
• Some defensiveness around “current is extremely volatile” rather than giving a clean forward number.

Theme C: FY27 outlook—volumes, margins, and “tipping point” viability

• Core questions
• Is there a gas-cost “tipping point” where plants become unviable?
• What upside/downside for FY27 if the scenario persists?
• Can margins reach low/mid-teens?
• Management response
• Volume: “decent single-digit growth” for tiles; sanitaryware/bathware “very healthy double digits.”
• Viability: argues they’re near historic price levels after 2 years of tile price declines; does not foresee shutdown unless extreme oil shock (e.g., “$200” oil).
• Margin: guidance is explicit—improve EBITDA margin by at least 1.5%+ from the base; also mentions 150 bps plus and “low/mid-teens” discussion in Q&A.
• Assessment
• The “tipping point” answer is qualitative and scenario-based, not quantified (no explicit gas price threshold).

Theme D: Morbi restart status, labor constraints, and competitive dynamics

• Core questions
• Morbi gas supply status and expected utilization ramp.
• Whether Morbi’s restart will hurt demand/volumes for organized players.
• Outsourced volume risk if Morbi remains weak.
• Management response
• Morbi gas from 1 May; ~60–65% running, expected ~85% by month end; remaining 10–15% likely won’t run due to inefficiency.
• Labor shortage is the key constraint; demand is weak currently but they expect “pent-up demand”.
• Competitive pricing: Morbi increased prices 30–35%, organized players 16–17%; management claims their relative increase is smaller.
• Outsourced/OEM plants: expects limited issue because OEM plants serve large organized players; material availability improves in May.
• Assessment
• Strong operational narrative, but relies on demand recovery timing (June/“by this month end or in June”)—still a dependency.

Theme E: Max plant breakeven sustainability & capex

• Core questions
• Is Max breakeven sustainable or one-off?
• What utilization is needed for Max to deliver EBITDA margin?
• Capex and debt repayment plans for FY27.
• Management response
• Max breakeven is framed as sustainable; inventory increase attributed to producing more with the new press.
• They invested INR 30 crores to improve utilization via a press.
• Capex: routine + balancing equipment, contained within INR 70–80 crores.
• Assessment
• Clear linkage between capex and utilization; credible because they quantify the investment.

4. Guidance / Outlook

Explicit guidance (quantitative)

• EBITDA margin improvement: “at least 1.5% or more” from here (from FY26 base).
• FY27 EBITDA margin direction: multiple mentions of ~150 bps+ improvement and “better than 10.8%” style framing in Q&A.
• Volume growth (tiles): “decent single-digit” for FY27.
• Sanitaryware/bathware growth: double-digit target (and “very healthy double digits”).
• Capex (FY27): INR 70–80 crores (routine + balancing equipment).
• Morbi utilization ramp (industry-level, not company guidance): ~85% by month end (labor-dependent).

Implicit signals (qualitative)

• Geopolitical caveat: guidance assumes “no further shocks geopolitically.”
• Pricing discipline expectation: management hopes market pricing discipline continues and references consolidation risk for Morbi players.
• Demand recovery timing: expects pent-up demand to materialize by month-end/June, but acknowledges April absorption delays.

5. Standout Statements (direct / revealing)

• Margin guidance: “improve EBITDA margin from here by at least 1.5% or more.”
• Geopolitical dependency: “there’s no further shocks geopolitically” (explicit caveat).
• Max turnaround: “we almost did a breakeven at Max plant” and Q4 breakeven vs prior-year loss.
• Working capital sustainability framed as controllable but uncertain: “a question mark… delayed response to price increases in April.”
• Morbi restart reality check: “approximately 60%, 65% of Morbi is up and running… 85%… balance 10% to 15%… I don’t think will run ever.”
• Cost pass-through claim: retail pass-through “100%”; projects “about 85%.”
• Viability stance: “I doubt there would be that situation where it won’t be viable to run the factory” (unless extreme oil shock).

6. Red Flags / Positive Signals

Red flags
– Reliance on demand timing: repeated references to pent-up demand arriving by end of month / June; if delayed, Morbi and channel inventory risk could reappear.
– Current gas pricing volatility: “current is extremely volatile” without a firm forward number.
– Working capital sustainability not fully assured: explicitly called a “question mark” due to April price absorption lag.

Positive signals
– Operational progress is tangible: Max plant breakeven and capex-linked utilization improvement.
– Balance sheet/working capital improvement is specific and large (receivables days down materially).
– Clear pass-through framework (retail vs projects percentages).
– Morbi competitive pressure narrative: inefficient players may shut down, supporting organized players.

7. Historical Comparison & Consistency Analysis (vs prior 3 calls provided)

a. Change in Tone Over Time

• Current call (Q4 FY26): More Optimistic
• Stronger confidence: “we are happy,” “very, very confident,” and explicit margin uplift guidance.
• Prior calls:
• Q2 FY26 (Nov 2025): more cautious/aberration framing due to outages; gas “flat,” but EBITDA down due to Kassar outage; still holding guidance.
• Q3 FY26 (Jan 2026): optimistic but still tied to JV losses (Max) and expecting stabilization in Q4/FY27.
• Shift classification: More Optimistic
• Management moved from “aberration/outage” and “hoping” to “guidance” and “breakeven” outcomes.

b. Tracking Past Commitments vs Outcomes

• Max plant breakeven / loss reduction
• Past statement (Q3 FY26 call, Jan 2026): losses to reduce; “in the next year… losses… brought down very significantly or probably we completely turn around the plant.”
• Expected by now: breakeven or near-breakeven in FY26/Q4.
• What happened (current call): “almost did a breakeven at Max plant” and Q4 breakeven vs prior-year loss.
• Flag: ✅ Delivered (at least materially improved; breakeven achieved in Q4).
• Gas pricing stability narrative
• Past (Q2 FY26): gas pricing “completely flat” and future “largely remain flat.”
• Current: gas prices increased “very significantly” post-war; current pricing “extremely volatile.”
• Flag: ❌ Missed / Narrative shift (stability assumption no longer holds).
• EBITDA margin improvement guidance
• Past (Q3 FY26): guidance to improve EBITDA margin by ~1% to 1.5% in Q4 FY26.
• Current: EBITDA improved strongly (Q4 EBITDA margin 11.4%; FY 9.3%) and now guidance for further +1.5%+.
• Flag: ✅ Mostly Delivered (directionally consistent with improvement).

c. Narrative Shifts

• From “gas stability” to “gas shock + pass-through”
• Earlier calls emphasized stability; now management centers the story on geopolitical-driven gas volatility and pricing discipline.
• Morbi disruption reframed
• Earlier: Morbi issues discussed as industry tailwind but more general.
• Now: detailed operational claims—Morbi gas supply start date, utilization ramp, labor shortage, and which portion won’t run—more concrete and more defensive.

d. Consistency & Credibility Signals

• Credibility: Medium
• Strength: operational milestones (Max breakeven) and working capital improvements are concrete.
• Weakness: gas pricing “flat” narrative in earlier calls conflicts with current “very significant increase” and “extremely volatile” framing.
• Management often uses scenario caveats (“if no further shocks”), which is reasonable but reduces certainty.

e. Evolution of Key Themes

• Demand: improving but timing-dependent (Jan–Feb recovery; March aberration; April absorption lag; pent-up demand expected).
• Margins: moving from outage-driven EBITDA pressure to margin expansion guidance tied to utilization and pass-through.
• Capacity utilization: consistently presented as the “biggest winner,” with utilization now reaching 100% running (with caveats about non-value-added kilns).
• Industry structure (Morbi): increasingly central—organized players benefit if inefficient Morbi capacity shuts down.

f. Additional Insights (Cross-Period Intelligence)

• Risk build-up masked earlier: gas “flat” talk in Q2/Q3 appears to have been overtaken by war-driven volatility; management now compensates with stronger pass-through claims and pricing discipline narrative.
• Channel/inventory management is becoming a key lever: working capital improvement and April inventory strategy (selling older/cheaper stock) suggest management is actively managing price absorption risk rather than relying purely on demand.
• Morbi labor constraint is now the gating factor: earlier calls focused more on gas and demand; now labor shortage is explicitly the reason Morbi won’t ramp quickly—this could delay the competitive normalization window.